Evidence map›Paper›PMID 31691891›Full record

ArticleGeroScience2020

Extracellular vesicles from mesenchymal stem cells reduce microglial-mediated neuroinflammation after cortical injury in aged Rhesus monkeys.

Veronica Go, Bethany G E Bowley, Monica A Pessina, Zheng Gang Zhang, Michael Chopp, Seth P Finklestein, Douglas L Rosene, Maria Medalla, Benjamin Buller, Tara L Moore

Open access · bronzeAbstract read
In one paragraph

Article in GeroScience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 1 synthesis or guideline pooled it, 120 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Veronica GoDeparment of Pharmacology & Experimental Therapeutics, Boston University School of Medicine, 700 Albany Street, W701, Boston, MA, 02118, USA. vgo@bu.edu.ORCID http://orcid.org/0000-0002-7709-3490
Bethany G E BowleyDepartment of Anatomy & Neurobiology, Boston University School of Medicine, Boston, 02118, USA.
Monica A PessinaDepartment of Anatomy & Neurobiology, Boston University School of Medicine, Boston, 02118, USA.
Zheng Gang ZhangDepartment of Neurology, Henry Ford Health Systems, Detroit, 48202, USA.
Michael ChoppDepartment of Neurology, Henry Ford Health Systems, Detroit, 48202, USA.
Seth P FinklesteinStemetix, Inc., Needham, 02492, USA.
Douglas L RoseneDeparment of Pharmacology & Experimental Therapeutics, Boston University School of Medicine, 700 Albany Street, W701, Boston, MA, 02118, USA.
Maria MedallaDepartment of Anatomy & Neurobiology, Boston University School of Medicine, Boston, 02118, USA.
Benjamin BullerDepartment of Neurology, Henry Ford Health Systems, Detroit, 48202, USA.
Tara L MooreDepartment of Anatomy & Neurobiology, Boston University School of Medicine, Boston, 02118, USA.
Boston University · USHenry Ford Health System · USMassachusetts General Hospital · US

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
TRAINING IN BIOMOLECULAR PHARMACOLOGYT32GM008541 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARB, DAVID H · 1997 to 2022
$5.2M
Translational Development of Glial Growth Factor 2 (GGF2) for the Treatment of StU01NS076474 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROSENE, DOUGLAS L · 2014 to 2017
$1.8M
Exosomes from bone marrow-derived mesenchymal stem cells as a restorative treatment in a non-human primate model of cerebral injuryR21NS102991 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MOORE, TARA L · 2017 to 2018
$465k
Recovery of Motor Function Impaired by Cortical Injury: An Exploratory Comparison of the Influences of Four Different Post-injury Treatments on Processes Affecting NeuroplasticityR21NS111174 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MOORE, TARA L, ROSENE, DOUGLAS L · 2019 to 2019
$454k
NCATS NIH HHS UL1 TR001430NIGMS NIH HHS T32 GM008541NINDS NIH HHS R21 NS102991NINDS NIH HHS R21 NS111174NINDS NIH HHS U01 NS076474
6 · The paper itself

Abstract

Cortical injury, such as injuries after stroke or age-related ischemic events, triggers a cascade of degeneration accompanied by inflammatory responses that mediate neurological deficits. Therapeutics that modulate such neuroinflammatory responses in the aging brain have the potential to reduce neurological dysfunction and promote recovery. Extracellular vesicles (EVs) from mesenchymal stem cells (MSCs) are lipid-bound, nanoscale vesicles that can modulate inflammation and enhance recovery in rodent stroke models. We recently assessed the efficacy of intravenous infusions of MSC-EVs (24-h and 14-days post-injury) as a treatment in aged rhesus monkeys (Macaca mulatta) with cortical injury that induced impairment of fine motor function of the hand. Aged monkeys treated with EVs after injury recovered motor function more rapidly and more fully than aged monkeys given a vehicle control. Here, we describe EV-mediated inflammatory changes using histological assays to quantify differences in markers of neuroinflammation in brain tissue between EV and vehicle-treated aged monkeys. The activation status of microglia, the innate macrophages of the brain, is critical to cell fate after injury. Our findings demonstrate that EV treatment after injury is associated with greater densities of ramified, homeostatic microglia, along with reduced pro-inflammatory microglial markers. These findings are consistent with a phenotypic switch of inflammatory hypertrophic microglia towards anti-inflammatory, homeostatic functions, which was correlated with enhanced functional recovery. Overall, our data suggest that EVs reduce neuroinflammation and shift microglia towards restorative functions. These findings demonstrate the therapeutic potential of MSC-derived EVs for reducing neuroinflammation after cortical injury in the aged brain.

Indexed as

Extracellular VesiclesMesenchymal Stem CellsAnimalsDisease Models, AnimalMacaca mulattaMicrogliaCortical injuryExtracellular vesiclesRhesus Monkeys

Identifiers

PMID31691891
PMCPMC7031476
OpenAlexW2989415456

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.